Price target
22.770.00 0.00%
The 5 analysts offering 1 year price forecasts for 471A have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to 471A in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
471A EPS for the last quarter is −0.21 EUR despite the estimation of −0.23 EUR. In the next quarter EPS is expected to reach −0.22 EUR. Track more of ATYR PHARMA INC. DL -,001 financials and stay on top of what is up with the company.
In the next quarter ATYR PHARMA INC. DL -,001 revenue is expected to reach 28.03 K EUR. Check out ATYR PHARMA INC. DL -,001 revenue and earnings and make informed decisions.
According to analysts, 471A price target is 22.77 EUR with a max estimate of 32.40 EUR and a min estimate of 14.81 EUR. Check if this forecast comes true in a year, meanwhile watch ATYR PHARMA INC. DL -,001 stock price chart and keep track of the current situation with 471A news and stock market news.
We've gathered opinions of 5 analysts rating 471A stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.